Sorrento Therapeutics, Inc. Annual Interest Expense in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2022.
  • Sorrento Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2023 was $2.67M, a 15.3% increase year-over-year.
  • Sorrento Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.81M, a 40.3% decline year-over-year.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2022 was $8.57M, a 16.1% decline from 2021.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2021 was $10.2M, a 49.3% decline from 2020.
  • Sorrento Therapeutics, Inc. annual Interest Expense for 2020 was $20.2M, a 42.5% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.57M -$1.65M -16.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $10.2M -$9.93M -49.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $20.2M -$14.9M -42.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $35M -$22.6M -39.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $57.6M +$52.7M +1057% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $4.98M +$3.37M +209% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $1.61M -$42K -2.54% Jan 1, 2016 Dec 31, 2016 8-K 2019-06-17
2015 $1.65M +$23K +1.41% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $1.63M +$1.38M +544% Jan 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
2013 $253K +$253K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.